Cargando…
COVID-19 Vaccination Willingness and Acceptability in Multiple Sclerosis Patients: A Cross Sectional Study in Iran
Multiple sclerosis (MS) is a chronic, predominantly immune-mediated degenerative disease of the central nervous system. Due to prolonged use of immunomodulatory and immunosuppressive medications, vaccine hesitancy could be common among MS patients. Our main aim in the current study was to evaluate t...
Autores principales: | Nabavi, Seyed Massood, Mehrabani, Mehrnoosh, Ghalichi, Leila, Nahayati, Mohammad Ali, Ghaffari, Mehran, Ashtari, Fereshteh, Mohammadianinejad, Seyed Ehsan, Karimi, Shahedeh, Faghani, Leila, Yazdanbakhsh, Sepideh, Najafian, Abbas, Shahpasand, Koorosh, Vosough, Massoud |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
MDPI
2022
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC8778456/ https://www.ncbi.nlm.nih.gov/pubmed/35062796 http://dx.doi.org/10.3390/vaccines10010135 |
Ejemplares similares
-
Safety and Efficacy of Allogeneic Adipose Tissue Mesenchymal
Stromal Cells in Amyotrophic Lateral Sclerosis Patients,
Single-Center, Prospective, Open-Label, Single-Arm
Clinical Trial, Long-Term Follow-up
por: Nabavi, Seyed Massood, et al.
Publicado: (2021) -
Advanced Therapy Medicinal Products in Vitiligo; Current Status,
Future Prospect, and Approved Treatments
por: Ghashghaei, Shahriar, et al.
Publicado: (2023) -
The most effective sexual function and dysfunction interventions in individuals with multiple sclerosis: A systematic review and meta-analysis
por: Afshar, Bahare, et al.
Publicado: (2022) -
The Effect of Disease Modifying Drugs of Multiple Sclerosis on the Effectiveness of BBIBP-CorV COVID19 Vaccine
por: Ghaffari, Mehran, et al.
Publicado: (2022) -
Cognitive dysfunction in multiple sclerosis: Usually forgotten in the clinical assessment of MS patients
por: Nabavi, Seyed Massood, et al.
Publicado: (2015)